JANE STREET GROUP, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2024$5,417,314
-70.9%
65,800
-69.1%
0.00%
-75.0%
Q1 2024$18,620,888
-1.5%
213,200
+8.7%
0.00%
-20.0%
Q4 2023$18,907,962
+302.4%
196,100
+269.3%
0.01%
+150.0%
Q3 2023$4,698,288
-14.1%
53,100
-15.8%
0.00%0.0%
Q2 2023$5,469,508
-55.5%
63,100
-50.1%
0.00%
-60.0%
Q1 2023$12,291,136
-45.6%
126,400
-42.1%
0.01%
-50.0%
Q4 2022$22,591,867
+8.8%
218,300
-10.9%
0.01%
+11.1%
Q3 2022$20,760,000
+4.2%
244,900
+1.9%
0.01%
+12.5%
Q2 2022$19,922,000240,4000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
Hudson Bay Capital Management LP 145,000$11,960,0000.56%
GROUP ONE TRADING, L.P. 65,100$5,369,0000.08%
Timber Hill LLC 38,500$3,175,0000.02%
SIMPLEX TRADING, LLC 438$141,0000.01%
Citadel Advisors 37,000$3,052,0000.00%
SG Americas Securities, LLC 14,000$49,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders